Richard L. Feinstein

Overview

Richard L. Feinstein received an average of $107K in total compensation at Enzon Pharmaceuticals from 2013 to 2016.

Source: SEC filings on May 12, 2017, May 13, 2016, and May 15, 2015.

Related executives

We found 12 more executives who work or worked at Enzon Pharmaceuticals.

Andrew Rackear

Enzon Pharmaceuticals

Chief Executive Officer

George Hebard

Enzon Pharmaceuticals

Chief Operating Officer

Aby Buchbinder

Enzon Pharmaceuticals

Former Vice President, Clinical Development

Charles Conover

Enzon Pharmaceuticals

Former Senior Vice President of Research & Development, Program Management

Timothy Daly

Enzon Pharmaceuticals

Chief Accounting Officer

Ana Stancic

Enzon Pharmaceuticals

Chief Financial Officer

Jeffrey Buchalter

Enzon Pharmaceuticals

Chief Executive Officer

Ralph del Campo

Enzon Pharmaceuticals

Chief Operating Officer

You may also like